| GENOVAC was first registered as a limited company
(GmbH) in December 1999 in Freiburg im Breisgau, South West
Germany, by Fritz Grunert, John Thompson and Wolfgang Zimmermann.
The three founders were group leaders at the Institute of Immunobiology,
University of Freiburg and have a longstanding experience in
tumor biology and the development of antibodies against carcinoembryonic
antigen (CEA) and related molecules. During this time, they
built up contacts to top laboratories working in the field of
tumor biology worldwide. As of 1st January 2004 GENOVAC became
a part of Aldevron
LLC, USA. Both companies have specialized in the area of
genetic immunization to develop antibodies. The combined expertise
and clientele in this area will make the new alliance a world-leader
in this technology. |
